Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients
- PMID: 8022107
Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients
Abstract
The serum levels of circulating immune complexes (CIC) measured by three different types of enzyme immunoassay (EIA) using monoclonal anti-C1q and antibodies and C1q as solid phase reagents were compared with clinical disease activity and immunohistological glomerular lesions in 29 SLE patients. Three types of CIC measured by these assays (anti-C1q CIC, anti-C3d CIC and C1q SP CIC) showed significantly higher levels in patients than in controls and were significantly associated with the clinical and serological disease activities. Anti-C1q CIC showed good correlation not only with mesangial IgG depositions (P < 0.01), but also with that of C1q (P < 0.05). C1q SP CIC also showed a weak correlation with mesangial C1q deposition (P < 0.05). Serum levels of anti-C3d CIC increased with the degree of mesangial IgG and complement depositions. Analysis of the clinical course of a patient with active SLE revealed a more rapid decrease of anti-C1q CIC and anti-C3d CIC along with the improvement of disease activity, including the mesangial lesion, than that of C1q SP CIC. According to these results, the CIC detected with assays using monoclonal antibodies against complement fragments, especially the anti-C1q assay, is likely to provide specific information regarding the clinical, serological and immunohistological disease activity in lupus nephritis.
Similar articles
-
Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.Clin Exp Immunol. 1984 Mar;55(3):487-94. Clin Exp Immunol. 1984. PMID: 6608422 Free PMC article.
-
Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.J Clin Lab Immunol. 1992;38(4):161-73. J Clin Lab Immunol. 1992. PMID: 11270517
-
The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.Clin Exp Immunol. 1982 Jun;48(3):726-32. Clin Exp Immunol. 1982. PMID: 6981475 Free PMC article.
-
[Current situation and problems in the estimation of circulating immune complexes].Rinsho Byori. 1992 Jan;40(1):28-33. Rinsho Byori. 1992. PMID: 1545522 Review. Japanese.
-
Extracorporeal removal of circulating immune complexes: from non-selective to patient-specific.Blood Purif. 2000;18(2):156-60. doi: 10.1159/000014441. Blood Purif. 2000. PMID: 10838476 Review.
Cited by
-
Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.Mediators Inflamm. 2016;2016:2196986. doi: 10.1155/2016/2196986. Epub 2016 Aug 11. Mediators Inflamm. 2016. PMID: 27597802 Free PMC article.
-
IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.Front Immunol. 2020 Jun 17;11:1047. doi: 10.3389/fimmu.2020.01047. eCollection 2020. Front Immunol. 2020. PMID: 32625200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous